Through empowering and educating patients, funding cutting-edge research, building strategic collaborations and raising public awareness, our goal is to transform lung cancer into a chronically managed disease within 10 years and ultimately to find a cure.

Latest News
Check Out the Latest News From ALCMICheck Out the Latest News From ALCMI // The Addario Lung Cancer Medical Institute’s (ALCMI) CASTLE study provides a unique foundational resource enabling scientists to ask and answer critical questions around the biology of lung cancer, and has... Read More READ MORE
Are you a ROS1+ patient?Are you a ROS1+ patient? // ALCF launched its Global ROS1 Initiative in 2016 to accelerate research into this understudied type of cancer. Learn more about how YOU can participate as we add the new ROS1... Read More READ MORE
Deadly, rare lung cancer finds big foe: Patients with little to loseDeadly, rare lung cancer finds big foe: Patients with little to lose // The San Francisco Business Times recently featured ALCF for the work we are doing, at the request of our patients, to study the ROS1 gene… Read More READ MORE
New Search Tool to Find Clinical TrialsNew Search Tool to Find Clinical Trials // New lung cancer treatments such as immunotherapy and targeted treatments are being researched in clinical trials every day, and we encourage you to get involved. That’s why we’re proud to... Read More READ MORE
Partners in Promise 2016Partners in Promise 2016 // Dear Friends, Lung cancer is personal for the people whose stories you will read in “Partners in Promise.” Many thanks to our “Patient Partners” for sharing their stories and to... Read More READ MORE